hero section gradient
18 handpicked stocks

Resilient Sportswear Plays Beyond The Tariff

Following Puma's significant profit warning due to U.S. tariffs, an investment opportunity emerges in the sportswear sector. This theme focuses on athletic apparel companies with resilient supply chains and less exposure to the trade policies impacting global brands.

Author avatar

Han Tan | Market Analyst

Published on July 25

Your Basket's Financial Footprint

Market cap breakdown for the 'Resilient Sportswear Plays Beyond The Tariff' basket and investor key takeaways.

Key Takeaways for Investors:
  • Large-cap dominance tends to reduce volatility, likely producing more stable, market-tracking returns than smaller-cap baskets.
  • Suitable as a core holding for diversification, not a speculative or high-growth allocation.
  • Expect steady long-term value rather than explosive short-term gains; growth likely modest and gradual.
Total Market Cap
  • LULU: $21.51B

  • NKE: $101.05B

  • UAA: $2.02B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Following Puma's profit warning due to U.S. tariffs, we identified a tactical opportunity in the sportswear sector. Companies with diversified or localized supply chains may demonstrate greater financial stability and potentially capture market share from more exposed competitors during this period of trade policy uncertainty.

2

What You Need to Know

This group focuses on athletic apparel and footwear companies that appear better positioned to navigate trade policy challenges. These stocks represent a tactical play on supply chain resilience, offering potential exposure to a sector-wide re-evaluation of manufacturing dependencies and market positioning.

3

Why These Stocks

Each company was handpicked by professional analysts based on their supply chain diversification and reduced exposure to U.S. tariffs on Asian imports. This curated selection aims to capitalize on near-term market dislocations while targeting firms that could benefit from competitors' vulnerabilities.

Why You'll Want to Watch These Stocks

Supply Chain Advantage

While competitors struggle with tariff impacts, these companies have built more resilient manufacturing networks. This positioning could translate into competitive advantages and market share gains.

📈

Sector Disruption Opportunity

Puma's profit warning signals broader industry vulnerabilities that could reshape the sportswear landscape. Companies with stronger supply chain strategies may emerge as clear winners.

🎯

Tactical Market Play

This theme captures a specific moment of market dislocation in the athletic apparel sector. Professional analysts selected these stocks to capitalize on near-term competitive shifts and supply chain re-evaluation.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions